Tax troubles see RESMED/IDR UNRESTR shares slide

Shares in medical product manufacturer RESMED/IDR UNRESTR (ASX: RMD) also known as ResMed Inc were down 0.7% to $12.59 at the time of writing after hitting 52-week high territory to finish off April with a $12.68 closing price.

ResMed has been hit with a US$190.1 million tax bill for the period between 2009 and 2013 following an audit of the company and ResMed announced on Friday it would pay US$151.7 million in additional income tax and US$38.4 million in interest after an amended assessment by the ATO.

ResMed is fighting the claim, but has coughed up half the additional tax in the interim.

Morgans has an add rating on the stock at present while Citigroup is more reluctant given the risk from competitors in the sleep apnoea mask space.

But there is plenty of growth left on the cards with ResMed seeing great gains from its cloud-based patient management system Airview, with 7 million patients now connected.

Brokers who have weighed in on ResMed appear to prefer it to peers Cochlear Limited (ASX: COH) and CSL Limited (ASX: CSL) at present in terms of growth prospects, with Cochlear shares up 0.4% to $194.84 at the time of writing and CSL down slightly to $169.89.

We all wish we'd bought Cochlear shares when they were much cheaper, and this Japanese Billionaire has some advice that could change our investing outlook forever.

When a veritable investing and entrepreneurial genius speaks, it pays to listen.

In fact, he's now preparing a $100B "war chest" to invest entirely in this "terrifying" new technology, which could spell huge profits for investors.

Click here to learn about this technology and how you can profit!

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.